Predictive biomarkers for the outcome of vaccination of five therapeutic epitope peptides for colorectal cancer.

نویسندگان

  • Shoichi Hazama
  • Hiroko Takenouchi
  • Ryouichi Tsunedomi
  • Michihisa Iida
  • Nobuaki Suzuki
  • Norio Iizuka
  • Yuka Inoue
  • Kazuhiko Sakamoto
  • Mitsuhiro Nakao
  • Yoshitaro Shindo
  • Shinsuke Kanekiyo
  • Yukio Tokumitsu
  • Kiyoshi Yoshimura
  • Noriko Maeda
  • Kazunari Maeda
  • Yoshinari Maeda
  • Hiroto Matsui
  • Shigefumi Yoshino
  • Yusuke Nakamura
  • Yusuke Fujita
  • Yoshihiko Hamamoto
  • Masato Okamoto
  • Tomonobu Fujita
  • Yutaka Kawakami
  • Masaaki Oka
چکیده

BACKGROUND We previously reported a phase I study of a cancer vaccine using five novel HLA-A*2402-restricted peptides, and demonstrated the safety and the promising potential of our five-peptide cocktail for advanced colorectal cancer. The objective of this analysis was to investigate predictive biomarkers for the prior selection of patients who are likely to have clinical benefit from such therapy. PATIENTS AND METHODS Seventeen patients with colorectal cancer who were treated with the five peptides underwent a complete blood count, serum chemistry tests and enzyme-linked ImmunoSpot assay before the treatment as predictive markers of high reactivity to the peptides. RESULTS Interleukin-6 level was a significant predictor for overall survival of patients treated with the peptide cocktail (p=0.017). A high neutrophil/lymphocyte ratio was likely to have some association with the poor induction of peptide-specific immune reaction. CONCLUSION Interleukin-6 level might be a good predictive biomarker for clinical benefit of patients treated with this peptide vaccine.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Immunoinformatics Design of a Multi-epitope-based Vaccine Against Colorectal Cancer

Background: Bioinformatic approaches for designing vaccines have become a promising alternative to conventional methods. We herein designed a multi-epitope-based vaccine against colorectal cancer (CRC). Methods: Used peptides in the CRC vaccines were retrieved from databases of PubMed, Web of Science, Google Scholar, and Clinical trials. The adjuvants of Mycobacterial heparin-binding hemagglut...

متن کامل

CEA Plasmid as Therapeutic DNA Vaccination against Colorectal Cancer

Background: Human colorectal cancer cells overexpress carcinoembryonic antigen (CEA). CEA is a glycoprotein which has shown to be a promising vaccine target for immunotherapy against colorectal cancer. Objective: To design a DNA vaccine harboring CEA antigen and evaluate its effect on inducing immunity against colorectal cancer cells in tumor bearing mice. <str...

متن کامل

Predictive Factors of Quality of Life in Patients with Colorectal cancer

Introduction: Colorectal cancer is one of the most common invasive cancers, and is &lrm;responsible for physical and psychosocial morbidity. Therefore, Quality of Life (QOL) is an &lrm;important outcome for these patients. Although extensive research has examined QOL in &lrm;patients with colorectal cancer, less research has examined factors that predict QOL. &lrm; &nbsp;Objective: The aim o...

متن کامل

Plasma Level of miRNA-7, miRNA-409 and miRNA-93 as Potential Biomarkers for Colorectal Cancer

Colorectal cancer (CRC) is among deadliest cancers all over the world. Regarding its high mortality, some researches have focused to discover new applicable diagnosis methods. In this regard, circulatory miRNAs has been received huge consideration as promising biomarkers for early detection of CRC. The study aimed to evaluate the expression level of miRNA-7, miRNA-93, and miRNA-409 in plasma of...

متن کامل

Scenario and future prospects of microRNAs in gastric cancer: A review

Carcinoma of the stomach is one of the major prevalent and principal causes of cancer-related deaths worldwide. Current advancement in technology has improved the understanding of the pathogenesis and pathology of gastric cancers (GC). But, high mortality rates, unfavorable prognosis and lack of clinical predictive biomarkers provide an impetus to investigate novel early diagnostic/prognostic m...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Anticancer research

دوره 34 8  شماره 

صفحات  -

تاریخ انتشار 2014